Clear Search sequence regions


  • allele (1)
  • birc5 protein, human (1)
  • cancer (9)
  • case control studies (1)
  • EFNA1 (10)
  • EGF (8)
  • genes (1)
  • humans (1)
  • iran (1)
  • protein human (2)
  • survivin (8)
  • Sizes of these terms reflect their relevance to your search.

    Genetic polymorphisms play an important role in the development of colorectal cancer (CRC). Functional variants in the epidermal growth factor (EGF), survivin, and Ephrin A1 (EFNA1) genes have been previously reported to play a potential role in susceptibility to CRC, but these polymorphisms have not been well replicated. The aim of this study was to assess the association of the EGF 61A>G, Survivin -31G>C, and EFNA1 -1732G>A polymorphisms with the susceptibility to CRC in an Iranian population. A total of 148 cases diagnosed with CRC and 160 healthy subjects were recruited. The EGF 61A>G, survivin -31G>C, and EFNA1 -1732G>A polymorphisms were genotyped using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Our data revealed that the homozygous mutant genotype (CC: OR = 2.895, 95% CI = 1.092-7.673, p = 0.033) and mutant allele (C: OR = 1.629, 95% CI = 1.152-2.303, p = 0.006) of the survivin -31G>C were associated with an increased risk of CRC in the Iranian population. However, our results failed to show an association between the EGF 61A>G and EFNA1 -1732G>A polymorphisms and CRC risk. Our results revealed that the survivin -31G>C polymorphism might play an important role in development of CRC in Iranian population. However, no association of EGF 61A>G and EFNA1 -1732G>A polymorphisms with CRC risk was found. © 2020. Springer Science+Business Media, LLC, part of Springer Nature.

    Citation

    Fatemeh Asadian, Mohammadamin Ghadyani, Mohamad Hossein Antikchi, Seyed Alireza Dastgheib, Hossein Neamatzadeh, Elnaz Sheikhpour, Sahel Khajehnoori, Seyed Sajjad Tabei. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer. Journal of gastrointestinal cancer. 2022 Mar;53(1):78-83

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33180239

    View Full Text